RA Capital Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,915,568
| Closed | -$19.5M | – | 91 |
|
|
2020
Q3 | $19.5M | Sell |
1,915,568
-579,123
| -23% | -$5.9M | 0.36% | 50 |
|
|
2020
Q2 | $37.2M | Sell |
2,494,691
-745,843
| -23% | -$11.1M | 0.72% | 34 |
|
|
2020
Q1 | $39.5M | Sell |
3,240,534
-123,071
| -4% | -$1.5M | 1.25% | 26 |
|
|
2019
Q4 | $53.2M | Hold |
3,363,605
| – | – | 1.61% | 18 |
|
|
2019
Q3 | $41.3M | Buy |
3,363,605
+619,980
| +23% | +$7.61M | 2.46% | 12 |
|
|
2019
Q2 | $36.2M | Buy |
+2,743,625
| New | +$36.2M | 1.94% | 14 |
|